|
Just over
half of older men with prostate cancer who opt for external beam
radiation therapy are alive a decade later, according to a new
study by Harvard researchers.
In a study
of 205 men who were treated for localized prostate cancer at a
median age of 72, the researchers found that 78 percent of the
men were alive after five years but only 53 percent survived 10
years.
Approximately
one third of the men who died during the 10-year period either
died from or with recurrent prostate cancer, the researchers found.
More than
half of those who were still alive after 10 years, however, were
disease free with stable prostate specific antigen (PSA) levels,
the researchers reported in the Journal of Urology.
The researchers
said their study provides a better basis for assessing the success
of radiation therapy than previous, shorther studies, and "provides
a yardstick against which newer radiation modalities may be measured."
Other
Sources: Journal of Urology
|